secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001628280-23-018467
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA approves Caldolor for infants aged 3-6 months; only injectable non-opioid for pain/fever in that age group
--------------------------------------------------------------------------------

- FDA approval expands Caldolor label to include infants 3 months to 6 months for pain and fever.
- Caldolor is now the only injectable non-opioid approved for pain treatment in infants.
- Approval based on a multi-center study in 21 hospitalized infants; safety and efficacy established from age 3 months.
- The company expects Caldolor to be eligible for special Medicare reimbursement under the NOPAIN Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023018467/0001628280-23-018467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023018467/cpix-20230516.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-018467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer